APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Soluble Guanylate Cyclase (sGC) Stimulators

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Soluble Guanylate Cyclase (sGC) Stimulators Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 174036870328 December 2025180 pages

Choose your research edition.

Industry ResearchSoluble Guanylate Cyclase (sGC) Stimulators Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Soluble Guanylate Cyclase (sGC) Stimulators Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Soluble Guanylate Cyclase (sGC) Stimulators Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Soluble Guanylate Cyclase (sGC) Stimulators Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Soluble Guanylate Cyclase (sGC) Stimulators Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Soluble Guanylate Cyclase (sGC) Stimulators market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Soluble Guanylate Cyclase (sGC) Stimulators is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Soluble Guanylate Cyclase (sGC) Stimulators is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Soluble Guanylate Cyclase (sGC) Stimulators is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Soluble Guanylate Cyclase (sGC) Stimulators is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Soluble Guanylate Cyclase (sGC) Stimulators include Cipla, Dr Reddy's Laboratories, MSN, Bayer and Merck, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Soluble Guanylate Cyclase (sGC) Stimulators market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Soluble Guanylate Cyclase (sGC) Stimulators and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Soluble Guanylate Cyclase (sGC) Stimulators sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Soluble Guanylate Cyclase (sGC) Stimulators market size, projected growth trends, production technologies, key applications, and end-use industries.

Soluble Guanylate Cyclase (sGC) Stimulators Segment by Company

Cipla

Dr Reddy's Laboratories

MSN

Bayer

Merck

Soluble Guanylate Cyclase (sGC) Stimulators Segment by Type

Vericiguat

Riociguat

Soluble Guanylate Cyclase (sGC) Stimulators Segment by Application

Chronic Thromboembolic Pulmonary Hypertension

Chronic Heart Failure

Pulmonary Hypertension

Other

Soluble Guanylate Cyclase (sGC) Stimulators Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Soluble Guanylate Cyclase (sGC) Stimulators market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Soluble Guanylate Cyclase (sGC) Stimulators and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Soluble Guanylate Cyclase (sGC) Stimulators.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Soluble Guanylate Cyclase (sGC) Stimulators market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Soluble Guanylate Cyclase (sGC) Stimulators manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Soluble Guanylate Cyclase (sGC) Stimulators in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Soluble Guanylate Cyclase (sGC) Stimulators in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Soluble Guanylate Cyclase (sGC) Stimulators Industry Trends Table 2. Soluble Guanylate Cyclase (sGC) Stimulators Industry Drivers Table 3. Soluble Guanylate Cyclase (sGC) Stimulators Industry Opportunities and Challenges Table 4. Soluble Guanylate Cyclase (sGC) Stimulators Industry Restraints Table 5. Global Soluble Guanylate Cyclase (sGC) Stimulators Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Soluble Guanylate Cyclase (sGC) Stimulators Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Soluble Guanylate Cyclase (sGC) Stimulators Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Soluble Guanylate Cyclase (sGC) Stimulators Sales Market Share by Manufacturers Table 9. Global Soluble Guanylate Cyclase (sGC) Stimulators Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Soluble Guanylate Cyclase (sGC) Stimulators Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Soluble Guanylate Cyclase (sGC) Stimulators Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Soluble Guanylate Cyclase (sGC) Stimulators Manufacturers, Product Type & Application Table 13. Global Soluble Guanylate Cyclase (sGC) Stimulators Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Soluble Guanylate Cyclase (sGC) Stimulators by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Vericiguat Table 17. Major Manufacturers of Riociguat Table 18. Global Soluble Guanylate Cyclase (sGC) Stimulators Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Soluble Guanylate Cyclase (sGC) Stimulators Sales by Type (2021-2026) & (K Units) Table 20. Global Soluble Guanylate Cyclase (sGC) Stimulators Sales by Type (2027-2032) & (K Units) Table 21. Global Soluble Guanylate Cyclase (sGC) Stimulators Sales Market Share by Type (2021-2026) Table 22. Global Soluble Guanylate Cyclase (sGC) Stimulators Sales Market Share by Type (2027-2032) Table 23. Global Soluble Guanylate Cyclase (sGC) Stimulators Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Soluble Guanylate Cyclase (sGC) Stimulators Revenue by Type (2021-2026) & (K Units) Table 25. Global Soluble Guanylate Cyclase (sGC) Stimulators Revenue by Type (2027-2032) & (K Units) Table 26. Global Soluble Guanylate Cyclase (sGC) Stimulators Revenue Market Share by Type (2021-2026) Table 27. Global Soluble Guanylate Cyclase (sGC) Stimulators Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Chronic Thromboembolic Pulmonary Hypertension Table 29. Major Manufacturers of Chronic Heart Failure Table 30. Major Manufacturers of Pulmonary Hypertension Table 31. Major Manufacturers of Other Table 32. Global Soluble Guanylate Cyclase (sGC) Stimulators Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Soluble Guanylate Cyclase (sGC) Stimulators Sales by Application (2021-2026) & (K Units) Table 34. Global Soluble Guanylate Cyclase (sGC) Stimulators Sales by Application (2027-2032) & (K Units) Table 35. Global Soluble Guanylate Cyclase (sGC) Stimulators Sales Market Share by Application (2021-2026) Table 36. Global Soluble Guanylate Cyclase (sGC) Stimulators Sales Market Share by Application (2027-2032) Table 37. Global Soluble Guanylate Cyclase (sGC) Stimulators Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 38. Global Soluble Guanylate Cyclase (sGC) Stimulators Revenue by Application (2021-2026) & (K Units) Table 39. Global Soluble Guanylate Cyclase (sGC) Stimulators Revenue by Application (2027-2032) & (K Units) Table 40. Global Soluble Guanylate Cyclase (sGC) Stimulators Revenue Market Share by Application (2021-2026) Table 41. Global Soluble Guanylate Cyclase (sGC) Stimulators Revenue Market Share by Application (2027-2032) Table 42. Global Soluble Guanylate Cyclase (sGC) Stimulators Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Soluble Guanylate Cyclase (sGC) Stimulators Sales by Region (2021-2026) & (K Units) Table 44. Global Soluble Guanylate Cyclase (sGC) Stimulators Sales Market Share by Region (2021-2026) Table 45. Global Soluble Guanylate Cyclase (sGC) Stimulators Sales Forecasted by Region (2027-2032) & (K Units) Table 46. Global Soluble Guanylate Cyclase (sGC) Stimulators Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Soluble Guanylate Cyclase (sGC) Stimulators Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 48. North America Soluble Guanylate Cyclase (sGC) Stimulators Sales by Country (2021-2026) & (K Units) Table 49. North America Soluble Guanylate Cyclase (sGC) Stimulators Sales by Country (2027-2032) & (K Units) Table 50. Europe Soluble Guanylate Cyclase (sGC) Stimulators Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 51. Europe Soluble Guanylate Cyclase (sGC) Stimulators Sales by Country (2021-2026) & (K Units) Table 52. Europe Soluble Guanylate Cyclase (sGC) Stimulators Sales by Country (2027-2032) & (K Units) Table 53. Asia Pacific Soluble Guanylate Cyclase (sGC) Stimulators Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Asia Pacific Soluble Guanylate Cyclase (sGC) Stimulators Sales by Country (2021-2026) & (K Units) Table 55. Asia Pacific Soluble Guanylate Cyclase (sGC) Stimulators Sales by Country (2027-2032) & (K Units) Table 56. South America, Middle East and Africa Soluble Guanylate Cyclase (sGC) Stimulators Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. South America, Middle East and Africa Soluble Guanylate Cyclase (sGC) Stimulators Sales by Country (2021-2026) & (K Units) Table 58. South America, Middle East and Africa Soluble Guanylate Cyclase (sGC) Stimulators Sales by Country (2027-2032) & (K Units) Table 59. Global Soluble Guanylate Cyclase (sGC) Stimulators Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Soluble Guanylate Cyclase (sGC) Stimulators Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Soluble Guanylate Cyclase (sGC) Stimulators Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Soluble Guanylate Cyclase (sGC) Stimulators Revenue Market Share by Region (2021-2026) Table 63. Global Soluble Guanylate Cyclase (sGC) Stimulators Revenue Market Share by Region (2027-2032) Table 64. Cipla Company Information Table 65. Cipla Business Overview Table 66. Cipla Soluble Guanylate Cyclase (sGC) Stimulators Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Cipla Soluble Guanylate Cyclase (sGC) Stimulators Product Portfolio Table 68. Cipla Recent Development Table 69. Dr Reddy's Laboratories Company Information Table 70. Dr Reddy's Laboratories Business Overview Table 71. Dr Reddy's Laboratories Soluble Guanylate Cyclase (sGC) Stimulators Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Dr Reddy's Laboratories Soluble Guanylate Cyclase (sGC) Stimulators Product Portfolio Table 73. Dr Reddy's Laboratories Recent Development Table 74. MSN Company Information Table 75. MSN Business Overview Table 76. MSN Soluble Guanylate Cyclase (sGC) Stimulators Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. MSN Soluble Guanylate Cyclase (sGC) Stimulators Product Portfolio Table 78. MSN Recent Development Table 79. Bayer Company Information Table 80. Bayer Business Overview Table 81. Bayer Soluble Guanylate Cyclase (sGC) Stimulators Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Bayer Soluble Guanylate Cyclase (sGC) Stimulators Product Portfolio Table 83. Bayer Recent Development Table 84. Merck Company Information Table 85. Merck Business Overview Table 86. Merck Soluble Guanylate Cyclase (sGC) Stimulators Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Merck Soluble Guanylate Cyclase (sGC) Stimulators Product Portfolio Table 88. Merck Recent Development Table 89. Key Raw Materials Table 90. Raw Materials Key Suppliers Table 91. Soluble Guanylate Cyclase (sGC) Stimulators Distributors List Table 92. Soluble Guanylate Cyclase (sGC) Stimulators Customers List Table 93. Research Programs/Design for This Report Table 94. Authors List of This Report Table 95. Secondary Sources Table 96. Primary Sources List of Figures Figure 1. Soluble Guanylate Cyclase (sGC) Stimulators Product Image Figure 2. Global Soluble Guanylate Cyclase (sGC) Stimulators Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Soluble Guanylate Cyclase (sGC) Stimulators Market Size (2021-2032) & (US$ Million) Figure 4. Global Soluble Guanylate Cyclase (sGC) Stimulators Sales (2021-2032) & (K Units) Figure 5. Global Soluble Guanylate Cyclase (sGC) Stimulators Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Soluble Guanylate Cyclase (sGC) Stimulators Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Vericiguat Image Figure 9. Riociguat Image Figure 10. Global Soluble Guanylate Cyclase (sGC) Stimulators Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Soluble Guanylate Cyclase (sGC) Stimulators Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Soluble Guanylate Cyclase (sGC) Stimulators Sales Market Share by Type (2021-2032) Figure 13. Global Soluble Guanylate Cyclase (sGC) Stimulators Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Soluble Guanylate Cyclase (sGC) Stimulators Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Soluble Guanylate Cyclase (sGC) Stimulators Revenue Market Share by Type (2021-2032) Figure 16. Chronic Thromboembolic Pulmonary Hypertension Image Figure 17. Chronic Heart Failure Image Figure 18. Pulmonary Hypertension Image Figure 19. Other Image Figure 20. Global Soluble Guanylate Cyclase (sGC) Stimulators Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Soluble Guanylate Cyclase (sGC) Stimulators Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Soluble Guanylate Cyclase (sGC) Stimulators Sales Market Share by Application (2021-2032) Figure 23. Global Soluble Guanylate Cyclase (sGC) Stimulators Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Soluble Guanylate Cyclase (sGC) Stimulators Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Soluble Guanylate Cyclase (sGC) Stimulators Revenue Market Share by Application (2021-2032) Figure 26. North America Soluble Guanylate Cyclase (sGC) Stimulators Sales and Growth Rate (2021-2032) & (K Units) Figure 27. North America Soluble Guanylate Cyclase (sGC) Stimulators Sales Market Share by Country (2021-2032) Figure 28. U.S. Soluble Guanylate Cyclase (sGC) Stimulators Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Canada Soluble Guanylate Cyclase (sGC) Stimulators Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Mexico Soluble Guanylate Cyclase (sGC) Stimulators Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Soluble Guanylate Cyclase (sGC) Stimulators Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Soluble Guanylate Cyclase (sGC) Stimulators Sales Market Share by Country (2021-2032) Figure 33. Germany Soluble Guanylate Cyclase (sGC) Stimulators Sales and Growth Rate (2021-2032) & (K Units) Figure 34. France Soluble Guanylate Cyclase (sGC) Stimulators Sales and Growth Rate (2021-2032) & (K Units) Figure 35. U.K. Soluble Guanylate Cyclase (sGC) Stimulators Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Italy Soluble Guanylate Cyclase (sGC) Stimulators Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Netherlands Soluble Guanylate Cyclase (sGC) Stimulators Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Soluble Guanylate Cyclase (sGC) Stimulators Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Soluble Guanylate Cyclase (sGC) Stimulators Sales Market Share by Country (2021-2032) Figure 40. China Soluble Guanylate Cyclase (sGC) Stimulators Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Japan Soluble Guanylate Cyclase (sGC) Stimulators Sales and Growth Rate (2021-2032) & (K Units) Figure 42. South Korea Soluble Guanylate Cyclase (sGC) Stimulators Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Southeast Asia Soluble Guanylate Cyclase (sGC) Stimulators Sales and Growth Rate (2021-2032) & (K Units) Figure 44. India Soluble Guanylate Cyclase (sGC) Stimulators Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Australia Soluble Guanylate Cyclase (sGC) Stimulators Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Soluble Guanylate Cyclase (sGC) Stimulators Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Soluble Guanylate Cyclase (sGC) Stimulators Sales Market Share by Country (2021-2032) Figure 48. Brazil Soluble Guanylate Cyclase (sGC) Stimulators Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South Africa Soluble Guanylate Cyclase (sGC) Stimulators Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Saudi Arabia Soluble Guanylate Cyclase (sGC) Stimulators Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Turkey Soluble Guanylate Cyclase (sGC) Stimulators Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Argentina Soluble Guanylate Cyclase (sGC) Stimulators Sales and Growth Rate (2021-2032) & (K Units) Figure 53. UAE Soluble Guanylate Cyclase (sGC) Stimulators Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Egypt Soluble Guanylate Cyclase (sGC) Stimulators Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Chile Soluble Guanylate Cyclase (sGC) Stimulators Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Global Soluble Guanylate Cyclase (sGC) Stimulators Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Soluble Guanylate Cyclase (sGC) Stimulators Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Soluble Guanylate Cyclase (sGC) Stimulators Revenue (2021-2032) & (US$ Million) Figure 59. North America Soluble Guanylate Cyclase (sGC) Stimulators Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Soluble Guanylate Cyclase (sGC) Stimulators Revenue (2021-2032) & (US$ Million) Figure 61. Europe Soluble Guanylate Cyclase (sGC) Stimulators Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Soluble Guanylate Cyclase (sGC) Stimulators Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Soluble Guanylate Cyclase (sGC) Stimulators Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Soluble Guanylate Cyclase (sGC) Stimulators Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Soluble Guanylate Cyclase (sGC) Stimulators Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Soluble Guanylate Cyclase (sGC) Stimulators Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Soluble Guanylate Cyclase (sGC) Stimulators Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Vericiguat
  • Riociguat
Applications
  • Chronic Thromboembolic Pulmonary Hypertension
  • Chronic Heart Failure
  • Pulmonary Hypertension
  • Other
Companies covered
  • Cipla
  • Dr Reddy's Laboratories
  • MSN
  • Bayer
  • Merck

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Soluble Guanylate Cyclase (sGC) Stimulators Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Soluble Guanylate Cyclase (sGC) Stimulators Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Soluble Guanylate Cyclase (sGC) Stimulators Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Soluble Guanylate Cyclase (sGC) Stimulators Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Soluble Guanylate Cyclase (sGC) Stimulators Market Dynamics
  1. 2.1 Soluble Guanylate Cyclase (sGC) Stimulators Industry Trends
  2. 2.2 Soluble Guanylate Cyclase (sGC) Stimulators Industry Drivers
  3. 2.3 Soluble Guanylate Cyclase (sGC) Stimulators Industry Opportunities and Challenges
  4. 2.4 Soluble Guanylate Cyclase (sGC) Stimulators Industry Restraints
3 Soluble Guanylate Cyclase (sGC) Stimulators Market by Manufacturers
  1. 3.1 Global Soluble Guanylate Cyclase (sGC) Stimulators Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Soluble Guanylate Cyclase (sGC) Stimulators Sales by Manufacturers (2021-2026)
  3. 3.3 Global Soluble Guanylate Cyclase (sGC) Stimulators Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Soluble Guanylate Cyclase (sGC) Stimulators Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Soluble Guanylate Cyclase (sGC) Stimulators Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Soluble Guanylate Cyclase (sGC) Stimulators Manufacturers, Product Type & Application
  7. 3.7 Global Soluble Guanylate Cyclase (sGC) Stimulators Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Soluble Guanylate Cyclase (sGC) Stimulators Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Soluble Guanylate Cyclase (sGC) Stimulators Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Soluble Guanylate Cyclase (sGC) Stimulators Tier 1, Tier 2, and Tier 3
4 Soluble Guanylate Cyclase (sGC) Stimulators Market by Type
  1. 4.1 Soluble Guanylate Cyclase (sGC) Stimulators Type Introduction
  2. 4.1.1 Vericiguat
  3. 4.1.2 Riociguat
  4. 4.2 Global Soluble Guanylate Cyclase (sGC) Stimulators Sales by Type
  5. 4.2.1 Global Soluble Guanylate Cyclase (sGC) Stimulators Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Soluble Guanylate Cyclase (sGC) Stimulators Sales by Type (2021-2032)
  7. 4.2.3 Global Soluble Guanylate Cyclase (sGC) Stimulators Sales Market Share by Type (2021-2032)
  8. 4.3 Global Soluble Guanylate Cyclase (sGC) Stimulators Revenue by Type
  9. 4.3.1 Global Soluble Guanylate Cyclase (sGC) Stimulators Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Soluble Guanylate Cyclase (sGC) Stimulators Revenue by Type (2021-2032)
  11. 4.3.3 Global Soluble Guanylate Cyclase (sGC) Stimulators Revenue Market Share by Type (2021-2032)
5 Soluble Guanylate Cyclase (sGC) Stimulators Market by Application
  1. 5.1 Soluble Guanylate Cyclase (sGC) Stimulators Application Introduction
  2. 5.1.1 Chronic Thromboembolic Pulmonary Hypertension
  3. 5.1.2 Chronic Heart Failure
  4. 5.1.3 Pulmonary Hypertension
  5. 5.1.4 Other
  6. 5.2 Global Soluble Guanylate Cyclase (sGC) Stimulators Sales by Application
  7. 5.2.1 Global Soluble Guanylate Cyclase (sGC) Stimulators Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Soluble Guanylate Cyclase (sGC) Stimulators Sales by Application (2021-2032)
  9. 5.2.3 Global Soluble Guanylate Cyclase (sGC) Stimulators Sales Market Share by Application (2021-2032)
  10. 5.3 Global Soluble Guanylate Cyclase (sGC) Stimulators Revenue by Application
  11. 5.3.1 Global Soluble Guanylate Cyclase (sGC) Stimulators Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Soluble Guanylate Cyclase (sGC) Stimulators Revenue by Application (2021-2032)
  13. 5.3.3 Global Soluble Guanylate Cyclase (sGC) Stimulators Revenue Market Share by Application (2021-2032)
6 Global Soluble Guanylate Cyclase (sGC) Stimulators Sales by Region
  1. 6.1 Global Soluble Guanylate Cyclase (sGC) Stimulators Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Soluble Guanylate Cyclase (sGC) Stimulators Sales by Region (2021-2032)
  3. 6.2.1 Global Soluble Guanylate Cyclase (sGC) Stimulators Sales by Region (2021-2026)
  4. 6.2.2 Global Soluble Guanylate Cyclase (sGC) Stimulators Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Soluble Guanylate Cyclase (sGC) Stimulators Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Soluble Guanylate Cyclase (sGC) Stimulators Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Soluble Guanylate Cyclase (sGC) Stimulators Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Soluble Guanylate Cyclase (sGC) Stimulators Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Soluble Guanylate Cyclase (sGC) Stimulators Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Soluble Guanylate Cyclase (sGC) Stimulators Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Soluble Guanylate Cyclase (sGC) Stimulators Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Soluble Guanylate Cyclase (sGC) Stimulators Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Soluble Guanylate Cyclase (sGC) Stimulators Revenue by Region
  1. 7.1 Global Soluble Guanylate Cyclase (sGC) Stimulators Revenue by Region
  2. 7.1.1 Global Soluble Guanylate Cyclase (sGC) Stimulators Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Soluble Guanylate Cyclase (sGC) Stimulators Revenue by Region (2021-2026)
  4. 7.1.3 Global Soluble Guanylate Cyclase (sGC) Stimulators Revenue by Region (2027-2032)
  5. 7.1.4 Global Soluble Guanylate Cyclase (sGC) Stimulators Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Soluble Guanylate Cyclase (sGC) Stimulators Revenue (2021-2032)
  8. 7.2.2 North America Soluble Guanylate Cyclase (sGC) Stimulators Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Soluble Guanylate Cyclase (sGC) Stimulators Revenue (2021-2032)
  11. 7.3.2 Europe Soluble Guanylate Cyclase (sGC) Stimulators Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Soluble Guanylate Cyclase (sGC) Stimulators Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Soluble Guanylate Cyclase (sGC) Stimulators Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Soluble Guanylate Cyclase (sGC) Stimulators Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Soluble Guanylate Cyclase (sGC) Stimulators Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Cipla
  2. 8.1.1 Cipla Company Information
  3. 8.1.2 Cipla Business Overview
  4. 8.1.3 Cipla Soluble Guanylate Cyclase (sGC) Stimulators Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Cipla Soluble Guanylate Cyclase (sGC) Stimulators Product Portfolio
  6. 8.1.5 Cipla Recent Developments
  7. 8.2 Dr Reddy's Laboratories
  8. 8.2.1 Dr Reddy's Laboratories Company Information
  9. 8.2.2 Dr Reddy's Laboratories Business Overview
  10. 8.2.3 Dr Reddy's Laboratories Soluble Guanylate Cyclase (sGC) Stimulators Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Dr Reddy's Laboratories Soluble Guanylate Cyclase (sGC) Stimulators Product Portfolio
  12. 8.2.5 Dr Reddy's Laboratories Recent Developments
  13. 8.3 MSN
  14. 8.3.1 MSN Company Information
  15. 8.3.2 MSN Business Overview
  16. 8.3.3 MSN Soluble Guanylate Cyclase (sGC) Stimulators Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 MSN Soluble Guanylate Cyclase (sGC) Stimulators Product Portfolio
  18. 8.3.5 MSN Recent Developments
  19. 8.4 Bayer
  20. 8.4.1 Bayer Company Information
  21. 8.4.2 Bayer Business Overview
  22. 8.4.3 Bayer Soluble Guanylate Cyclase (sGC) Stimulators Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Bayer Soluble Guanylate Cyclase (sGC) Stimulators Product Portfolio
  24. 8.4.5 Bayer Recent Developments
  25. 8.5 Merck
  26. 8.5.1 Merck Company Information
  27. 8.5.2 Merck Business Overview
  28. 8.5.3 Merck Soluble Guanylate Cyclase (sGC) Stimulators Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Merck Soluble Guanylate Cyclase (sGC) Stimulators Product Portfolio
  30. 8.5.5 Merck Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Soluble Guanylate Cyclase (sGC) Stimulators Value Chain Analysis
  2. 9.1.1 Soluble Guanylate Cyclase (sGC) Stimulators Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Soluble Guanylate Cyclase (sGC) Stimulators Production Mode & Process
  6. 9.2 Soluble Guanylate Cyclase (sGC) Stimulators Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Soluble Guanylate Cyclase (sGC) Stimulators Distributors
  9. 9.2.3 Soluble Guanylate Cyclase (sGC) Stimulators Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst